|
1
|
Chan JR, Blumenschein W, Murphy E, Diveu
C, Wiekowski M, Abbondanzo S, Lucian L, Geissler R, Brodie S,
Kimball AB, et al: IL-23 stimulates epidermal hyperplasia via TNF
and IL-20R2-dependent mechanisms with implications for psoriasis
pathogenesis. J Exp Med. 203:2577–2587. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rácz E, Kurek D, Kant M, Baerveldt EM,
Florencia E, Mourits S, de Ridder D, Laman JD, van der Fits L and
Prens EP: GATA3 expression is decreased in psoriasis and during
epidermal regeneration; induction by narrow-band UVB and IL-4. PLoS
One. 6:e198062011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lowes MA, Bowcock AM and Krueger JG:
Pathogenesis and therapy of psoriasis. Nature. 445:866–873. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gaspari AA: Innate and adaptive immunity
and the pathophysiology of psoriasis. J Am Acad Dermatol. 54(Suppl
2): S67–S80. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lew W, Bowcock AM and Krueger JG:
Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell
activation and 'Type 1' inflammatory gene expression. Trends
Immunol. 25:295–305. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Di Cesare A, Di Meglio P and Nestle FO:
The IL-23/Th17 axis in the immunopathogenesis of psoriasis. J
Invest Dermatol. 129:1339–1350. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Blauvelt A: T-helper 17 cells in psoriatic
plaques and additional genetic links between IL-23 and psoriasis. J
Invest Dermatol. 128:1064–1067. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pène J, Chevalier S, Preisser L, Vénéreau
E, Guilleux MH, Ghannam S, Molès JP, Danger Y, Ravon E, Lesaux S,
et al: Chronically inflamed human tissues are infiltrated by highly
differentiated Th17 lymphocytes. J Immunol. 180:7423–7430. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
McGeachy MJ, Chen Y, Tato CM, Laurence A,
Joyce-Shaikh B, Blumenschein WM, McClanahan TK, O'Shea JJ and Cua
DJ: The interleukin 23 receptor is essential for the terminal
differentiation of interleukin 17-producing effector T helper cells
in vivo. Nat Immunol. 10:314–324. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tonel G, Conrad C, Laggner U, Di Meglio P,
Grys K, McClanahan TK, Blumenschein WM, Qin JZ, Xin H, Oldham E, et
al: Cutting edge: a critical functional role for IL-23 in
psoriasis. J Immunol. 185:5688–5691. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mabuchi T, Takekoshi T and Hwang ST:
Epidermal CCR6+ γδ T cells are major producers of IL-22
and IL-17 in a murine model of psoriasiform dermatitis. J Immunol.
187:5026–5031. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Johnson-Huang LM, Suárez-Fariñas M,
Sullivan-Whalen M, Gilleaudeau P, Krueger JG and Lowes MA:
Effective narrow-band UVB radiation therapy suppresses the
IL-23/IL-17 axis in normalized psoriasis plaques. J Invest
Dermatol. 130:2654–2663. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nograles KE, Davidovici B and Krueger JG:
New insights in the immunologic basis of psoriasis. Semin Cutan Med
Surg. 29:3–9. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wan Y, Gu L, Suzuki K, Karasawa T, Fujioka
Y, Han GD, Koike H, Kawachi H and Shimizu F: Multi-glycoside of
Tripterygium wilfordii Hook.f. ameliorates proteinuria and acute
mesangial injury induced by anti-Thy1.1 monoclonal antibody.
Nephron, Exp Nephrol. 99:e121–e129. 2005. View Article : Google Scholar
|
|
15
|
Zhan QX and Xu LM: Effiency of
Tripterygium Wilfordii on treating psoriasis:A systematic review.
Chin J Dermatovenerol Integr Trad West Med. 6:192–196. 2007.
|
|
16
|
van der Fits L, Mourits S, Voerman JS,
Kant M, Boon L, Laman JD, Cornelissen F, Mus AM, Florencia E, Prens
EP and Lubberts E: Imiquimod-induced psoriasis-like skin
inflammation in mice is mediated via the IL-23/IL-17 axis. J
Immunol. 182:5836–5845. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kagami S, Rizzo HL, Lee JJ, Koguchi Y and
Blauvelt A: Circulating Th17, Th22, and Th1 cells are increased in
psoriasis. J Invest Dermatol. 130:1373–1383. 2010. View Article : Google Scholar :
|
|
18
|
Lowes MA, Kikuchi T, Fuentes-Duculan J,
Cardinale I, Zaba LC, Haider AS, Bowman EP and Krueger JG:
Psoriasis vulgaris lesions contain discrete populations of Th1 and
Th17 T cells. J Invest Dermatol. 128:1207–1211. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Harper EG, Guo C, Rizzo H, Lillis JV,
Kurtz SE, Skorcheva I, Purdy D, Fitch E, Iordanov M and Blauvelt A:
Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro
and in vivo: implications for psoriasis pathogenesis. J Invest
Dermatol. 129:2175–2183. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yilmaz SB, Cicek N, Coskun M, Yegin O and
Alpsoy E: Serum and tissue levels of IL-17 in different clinical
subtypes of psoriasis. Arch Dermatol Res. 304:465–469. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ota T, Takekoshi S, Takagi T, Kitatani K,
Toriumi K, Kojima T, Kato M, Ikoma N, Mabuchi T and Ozawa A: Notch
signaling may be involved in the abnormal differentiation of
epidermal keratinocytes in psoriasis. Acta Histochem Cytochem.
47:175–183. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang L, Yang XQ, Cheng J, Hui RS and Gao
TW: Increased Th17 cells are accompanied by FoxP3(+) Treg cell
accumulation and correlated with psoriasis disease severity. Clin
Immunol. 135:108–117. 2010. View Article : Google Scholar
|
|
23
|
Cai Y, Shen X, Ding C, Qi C, Li K, Li X,
Jala VR, Zhang HG, Wang T, Zheng J and Yan J: Pivotal role of
dermal IL-17-producing γδ T cells in skin inflammation. Immunity.
35:596–610. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pantelyushin S, Haak S, Ingold B, Kulig P,
Heppner FL, Navarini AA and Becher B: Rorγt+ innate
lymphocytes and γδ T cells initiate psoriasiform plaque formation
in mice. J Clin Invest. 122:2252–2256. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
O'Shea JJ, Steward-Tharp SM, Laurence A,
Watford WT, Wei L, Adamson AS and Fan S: Signal transduction and
Th17 cell differentiation. Microbes Infect. 11:599–611. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dong C: TH17 cells in development: an
updated view of their molecular identity and genetic programming.
Nat Rev Immunol. 8:337–348. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li Y, Yu C, Zhu WM, Xie Y, Qi X, Li N and
Li JS: Triptolide ameliorates IL-10-deficient mice colitis by
mechanisms involving suppression of IL-6/STAT3 signaling pathway
and down-regulation of IL-17. Mol Immunol. 47:2467–2474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gomez-Rodriguez J, Sahu N, Handon R,
Davidson TS, Anderson SM, Kirby MR, August A and Schwartzberg PL:
Differential expression of interleukin-17A and -17F is coupled to T
cell receptor signaling via inducible T cell kinase. Immunity.
31:587–597. 2009. View Article : Google Scholar : PubMed/NCBI
|
